In terms of mechanism, MEG3 may inhibit the growth of cancer cells and induce their apoptosis by activating ER stress, nuclear factor-κB (NF-κB), and p53 pathways, and it may eventually affect the response to chemotherapy. Here, MEG3 is linked to cancer.